>
Trump Slams 'Crazy' Rand Paul Over Opposition To Monster Debt Increase In 'BBB'
Trump's Palantir-Powered Surveillance Is Turning America Into a Digital Prison
BIG BEAUTIFUL DISASTER: Republicans Delay Doge Cuts As Musk Trump and the Senate...
BREAKING MEDICAL DISASTER: Trump Admin Reverses Course...
New AI data centers will use the same electricity as 2 million homes
Is All of This Self-Monitoring Making Us Paranoid?
Cavorite X7 makes history with first fan-in-wing transition flight
Laser-powered fusion experiment more than doubles its power output
Watch: Jetson's One Aircraft Just Competed in the First eVTOL Race
Cab-less truck glider leaps autonomously between road and rail
Can Tesla DOJO Chips Pass Nvidia GPUs?
Iron-fortified lumber could be a greener alternative to steel beams
One man, 856 venom hits, and the path to a universal snakebite cure
Dr. McCullough reveals cancer-fighting drug Big Pharma hopes you never hear about…
Scientists at University College London (UCL) have demonstrated in rodents a new type of "micromagnet" that can work as a miniaturized mechanical switch to turn on touch-sensitive cells, offering a new method for controlling specific regions of the brain.
There are parallels between this breakthrough and another exciting branch of research focused on careful control of cells in the body, known as optogenetics. This technique involves inserting genes into otherwise regular calls to make them sensitive to light, allowing them to be stimulated for the purposes of treating paralysis, relieving pain and restoring vision.
Although there have been success stories, such as a case when optogenetics was used for partial vision restoration in a human for the first time last year, adapting the technology for clinical use has proven difficult due to the need for genetic modification of the cells. The UCL team has come up with another way of controlling brain activity that doesn't involve such measures.
"Our new technology uses magnetic particles and magnets to remotely and precisely control brain cell activity and, importantly, does this without introducing any device or foreign gene into the brain," said lead researcher Dr Yichao Yu.
The team's magnet-centric approach involves targeting brain cells called astrocytes, which live between the brain's blood vessels and nerve cells and supply neurons with metabolic and structural support, while also regulating activity of neuronal circuits. Conveniently for the scientists, they also happen to be touch-sensitive.
"Because astrocytes are sensitive to touch, decorating them with magnetic particles means you can give the cells a tiny prod from outside the body using a magnet, and as such, control their function," said senior author, Professor Mark Lythgoe. "This ability to remotely control astrocytes provides a new tool for understanding their function and may have the potential to treat brain and mood disorders, including depression."